The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.
Ido LaishMenachem SchechterAlain DancourSari LiebermanZohar LeviYael GoldbergInbal KedarErez HasnisElizabeth E HalfGili Reznick LeviLior KatzElez D VainerDor GenzelMaya AharoniRakefet Chen-ShtoyermanNaim Abu-FrehaMaria Raitses-GurevichTalia GolanRinat Bernstein-MolhoMerav Ben YehoyadaNathan GluckGuy RosnerPublished in: Cancer (2023)
Despite the low detection rate of PDAC and its' high-risk neoplastic precursor lesions among BRCA1/2 carriers undergoing pancreatic surveillance, 75% of cancer cases were detected at a resectable stage.
Keyphrases